Sanofi to market new hemophilia drug in deal with Alnylam

PARIS (Reuters) - French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its partnership with U.S. Alnylam Pharmaceuticals.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news